MedPath

Developmental Effects of Infant Formula Supplemented With LCPUFA

Not Applicable
Completed
Conditions
Cognitive Development
Growth
Registration Number
NCT00753818
Lead Sponsor
Mead Johnson Nutrition
Brief Summary

The purpose of this study is to compare the effects on visual development, growth, cognitive development, tolerance, and blood chemistry parameters in term infants fed one of four study formulas containing various levels of DHA and ARA.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • healthy, term, formula fed infants from 1-5 days of age
Exclusion Criteria
  • history of disease that effects normal growth and development
  • breast fed, or formula intolerance

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
visual development
Secondary Outcome Measures
NameTimeMethod
Cognitive development

Trial Locations

Locations (2)

The University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

The University of Texas Southwestern Medical Center at Dallas

🇺🇸

Dallas, Texas, United States

The University of Kansas Medical Center
🇺🇸Kansas City, Kansas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.